Centessa Pharmaceuticals plc (LON:0ACX)
39.59
-0.01 (-0.02%)
At close: May 8, 2026
Centessa Pharmaceuticals Revenue
In the year 2025, Centessa Pharmaceuticals had annual revenue of $15.00M USD.
Revenue
$15.00M
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
$127.12K
Employees
118
Market Cap
4.50B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.00M | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 6.85M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kingfisher | 12.95B |
| Balfour Beatty | 9.49B |
| Computacenter | 9.19B |
| Zegona Communications | 2.62B |
| Howden Joinery Group | 2.42B |
| Burberry Group | 2.41B |
| Ithaca Energy | 2.19B |
| Lion Finance Group | 1.21B |
Centessa Pharmaceuticals News
- 21 days ago - Centessa downgraded to Equal Weight from Overweight at Wells Fargo - TheFly
- 4 weeks ago - Centessa downgraded to Hold from Buy at Truist - TheFly
- 5 weeks ago - Centessa downgraded to Neutral from Buy at Guggenheim - TheFly
- 5 weeks ago - Centessa downgraded to Market Perform from Outperform at LifeSci Capital - TheFly
- 5 weeks ago - Centessa downgraded to Market Perform from Outperform at Leerink - TheFly
- 5 weeks ago - Nxera Pharma's Partner Centessa Pharmaceuticals to be Acquired by Lilly - GlobeNewsWire
- 5 weeks ago - Alkermes jumps 15% on renewed biotech M&A buzz, says Leerink - TheFly
- 5 weeks ago - Centessa acquisition ‘may help rouse’ Alkermes shares, says RBC Capital - TheFly